Infectious Diseases News and Research

RSS

Researchers identify the role of iron in ocular toxoplasmosis

Researchers from Nagoya University Graduate School of Medicine have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness.

14 Nov 2023

Study reveals mechanisms underlying non-suppressible HIV viremia

Human immunodeficiency virus (HIV) works by entering specific immune cells and replicating inside them.

14 Nov 2023

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people.

14 Nov 2023

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test-;a phenomenon known as virologic rebound.

13 Nov 2023

Study reveals underuse of antiviral medications in young children with influenza

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a new study reports an underuse of the treatment.

13 Nov 2023

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

From ATCC 13 Nov 2023

Vitamin D supplementation may reduce future dementia risk, study suggests

Everyone knows that vitamin D is vital for healthy bones and a stronger immune system but could low levels be a major driver of Alzheimer’s and age-related cognitive decline?

13 Nov 2023

New study sheds light on the genes and nutrients that give MAIT cells their fighting power

Scientists at La Jolla Institute for Immunology (LJI) are investigating a talented type of T cell.

10 Nov 2023

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Neuropsychiatric symptoms of Long COVID, including brain fog, inability to concentrate, and headache, have puzzled researchers and clinicians, who are hunting for those symptoms' causes.

10 Nov 2023

Open-science drug discovery campaign yields a wealth of data on SARS-CoV-2 main protease

Although the group's work has been freely available since its inception in March 2020, the COVID Moonshot Consortium is finally formally reporting their results.

9 Nov 2023

COVID Moonshot Consortium makes major breakthrough in antiviral drug discovery

The work of the COVID Moonshot Consortium is being published in the prestigious journal Science on 10 November, revealing their discovery of a potent SARS-CoV-2 antiviral lead compound.

9 Nov 2023

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

9 Nov 2023

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Since then, extensive efforts have been made to develop and evaluate vaccines to combat the virus.

8 Nov 2023

Study sheds new light on the variety of cellular causes of rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation that leads to pain, joint damage, and disability, which affects approximately 18 million people worldwide.

8 Nov 2023

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Karl Klose, director of The South Texas Center for Emerging Infectious Diseases (STCEID) and the Robert J. Kleberg, Jr. and Helen C. Kleberg College of Sciences Endowed Professor, coauthored a research article with Cameron Lloyd '23, a UTSA doctoral student who graduated in August with a Ph.D. in molecular microbiology and immunology under the guidance of Klose.

7 Nov 2023

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Stellaromics today announced that the company has raised $25 million in a Series A financing round.

7 Nov 2023

Researchers identify a 'Threshold of Immunity' to SARS-CoV-2

How much immunity do we need against COVID-19? New international research led by scientists in Ireland and published in Nature Communications, has identified a 'Threshold of Immunity' to SARS-CoV-2.

6 Nov 2023

Avian flu decimates 5% of Peru's sea lions, sparking conservation alarm

Over 5,000 Peruvian sea lions, approximately 5% of Peru's population, succumbed to a mass mortality event linked to the avian influenza A(H5N1) virus, signaling an urgent need for research and conservation efforts to prevent further declines. The rapid spread of the virus among these colonially breeding mammals highlights potential risks of cross-species transmission and the necessity for heightened monitoring to avert new pandemics.

5 Nov 2023

New pathway to combat cardiovascular disease identified

Research led by the University of Minnesota Medical School identified a new pathway to combat cardiovascular disease. The study was recently published in Nature Cardiovascular Research.

3 Nov 2023

States reconsider religious exemptions for vaccinations in child care

More than half the children who attend Munchkin Land Daycare near Billings, Montana, have special needs or compromised immune systems.

3 Nov 2023

Infectious Diseases News and Research

Researchers identify the role of iron in ocular toxoplasmosis

Study reveals mechanisms underlying non-suppressible HIV viremia

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

Study reveals underuse of antiviral medications in young children with influenza

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

Vitamin D supplementation may reduce future dementia risk, study suggests

New study sheds light on the genes and nutrients that give MAIT cells their fighting power

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Open-science drug discovery campaign yields a wealth of data on SARS-CoV-2 main protease

COVID Moonshot Consortium makes major breakthrough in antiviral drug discovery

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

Study sheds new light on the variety of cellular causes of rheumatoid arthritis

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Stellaromics secures $25 million in series a funding to advance 3D spatial multi-omic profiling

Researchers identify a 'Threshold of Immunity' to SARS-CoV-2

Avian flu decimates 5% of Peru's sea lions, sparking conservation alarm

New pathway to combat cardiovascular disease identified

States reconsider religious exemptions for vaccinations in child care

NGS for Infectious Disease Surveillance eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News